Division of Neurosurgery, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Ontario, Canada.
Harquail Centre for Neuromodulation, Hurvitz Brain Sciences Program, Sunnybrook Research Institute, Toronto, Ontario, Canada.
J Neurol Neurosurg Psychiatry. 2022 Feb;93(2):207-215. doi: 10.1136/jnnp-2020-325308. Epub 2021 Jul 14.
Four ablative neurosurgical procedures are used in the treatment of refractory psychiatric illness. The long-term effects of these procedures on psychiatric symptoms across disorders has never been synthesised and meta-analysed.
A preregistered systematic review was performed on studies reporting clinical results following ablative psychiatric neurosurgery. Four possible outcome measures were extracted for each study: depression, obsessive-compulsive symptoms, anxiety and clinical global impression. Effect sizes were calculated using Hedge's g. Equipercentile linking was used to convert symptom scores to a common metric. The main outcome measures were the magnitude of improvement in depression, obsessive compulsive symptoms, anxiety and clinical global impression. The secondary outcome was a subgroup analysis comparing the magnitude of symptom changes between the four procedures.
Of 943 articles, 43 studies reporting data from 1414 unique patients, were included for pooled effects estimates with a random-effects meta-analysis. Results showed that there was a large effect size for improvements in depression (g=1.27; p<0.0001), obsessive-compulsive symptoms (g=2.25; p<0.0001) and anxiety (g=1.76; p<0.0001). The pooled clinical global impression improvement score was 2.36 (p<0.0001). On subgroup analysis, there was only a significant degree of heterogeneity in effect sizes between procedure types for anxiety symptoms, with capsulotomy resulting in a greater reduction in anxiety than cingulotomy.
Contemporary ablative neurosurgical procedures were significantly associated with improvements in depression, obsessive-compulsive symptoms, anxiety and clinical global impression.
CRD42020164784.
有四种消融性神经外科手术被用于治疗难治性精神疾病。这些手术在跨障碍的精神症状方面的长期效果从未被综合和荟萃分析过。
对报告消融性精神神经外科手术后临床结果的研究进行了预先注册的系统评价。从每项研究中提取了四种可能的结果测量值:抑郁、强迫症症状、焦虑和临床总体印象。使用 Hedge's g 计算效应量。等百分位链接用于将症状评分转换为通用指标。主要结局指标是抑郁、强迫症症状、焦虑和临床总体印象改善的程度。次要结局是比较四种手术之间症状变化程度的亚组分析。
在 943 篇文章中,有 43 项研究报告了来自 1414 名独特患者的数据,这些研究被纳入了随机效应荟萃分析的汇总效应估计中。结果表明,抑郁(g=1.27;p<0.0001)、强迫症症状(g=2.25;p<0.0001)和焦虑(g=1.76;p<0.0001)的改善具有较大的效应量。汇总的临床总体印象改善评分是 2.36(p<0.0001)。在亚组分析中,只有焦虑症状的手术类型之间的效应量存在显著程度的异质性,壳核切开术导致的焦虑减轻程度大于扣带回切开术。
当代消融性神经外科手术与抑郁、强迫症症状、焦虑和临床总体印象的改善显著相关。
PROSPERO 注册号:CRD42020164784。